Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-03-12 Sale | 2025-03-12 6:13 pm | Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director | 35,000 | $5.83 | $204,050 | 101,100 (Direct) | View |
2025-03-12 Sale | 2025-03-12 6:13 pm | Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director | 10,000 | $5.73 | $57,300 | 44,482 (Direct) | View |
2025-02-12 Sale | 2025-03-04 4:08 pm | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 29,991 | $0 | $0 | 114,156 (Direct) | View |
2025-02-12 Sale | 2025-03-04 4:05 pm | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 16,916 | $0 | $0 | 152,337 (Direct) | View |
2024-11-12 Sale | 2024-11-14 4:18 pm | Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director | 25,000 | $10.91 | $272,750 | 111,100 (Direct) | View |
2024-11-11 Sale | 2024-11-13 4:04 pm | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 14,287 | $11.97 | $171,015 | 54,092 (Direct) | View |
2024-06-04 Sale | 2024-06-06 4:16 pm | Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director | 10,000 | $6.11 | $61,100 | 54,482 (Direct) | View |
2024-05-29 Sale | 2024-05-31 3:02 pm | Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director | 1,830 | $4.61 | $8,436 | 64,482 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-04-07 Tax Withholding | 2025-04-09 6:36 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 561 | $4.44 | 109,122 (Direct) | View |
2025-04-07 Tax Withholding | 2025-04-09 6:35 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 480 | $4.44 | 176,176 (Direct) | View |
2025-03-06 Option Award(A) | 2025-04-09 6:31 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 62,500 | $0 | 109,683 (Direct) | View |
2025-03-12 Option Award | 2025-03-12 6:12 pm | 2025-03-12 2031-03-12 | Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO | 500,000 | $0 | 2,815,000 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:18 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec | 62,500 | $0 | 164,332 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:18 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 62,500 | $0 | 296,449 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:18 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 325,434 | $0 | 783,715 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:17 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO | 62,500 | $0 | 194,981 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:17 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 62,500 | $0 | 324,686 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:17 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO | 282,500 | $0 | 1,315,000 (Direct) | View |
2025-03-06 Option Award | 2025-03-10 4:17 pm | N/A 2032-03-05 | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 62,500 | $0 | 426,269 (Direct) | View |
2025-03-05 Tax Withholding | 2025-03-07 4:39 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 292 | $5.8 | 47,183 (Direct) | View |
2025-03-01 Tax Withholding | 2025-03-04 4:08 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 313 | $7.48 | 114,156 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-04 4:06 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 498 | $7.48 | 23,835 (Direct) | View |
2025-02-28 Tax Withholding | 2025-03-04 4:05 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 1,756 | $7.48 | 152,337 (Direct) | View |
2025-02-09 Tax Withholding | 2025-02-11 4:01 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec | 918 | $10 | 5,887 (Direct) | View |
2024-12-15 Option Award | 2024-12-17 5:44 pm | N/A 2031-12-14 | Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO | 69,981 | $0 | 69,981 (Direct) | View |
2024-12-08 Tax Withholding | 2024-12-10 4:02 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 18,674 | $9.01 | 144,460 (Direct) | View |
Ownership | 2024-11-21 4:02 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Lowry Simon C SVP, R&D, CMO | 0 | $0 | 0 (Direct) | View |
2024-11-11 Tax Withholding | 2024-11-13 4:04 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 632 | $11.97 | 47,475 (Direct) | View |
Ownership | 2024-11-12 4:26 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Perl Jessica SVP, General Counsel, Corp Sec | 0 | $0 | 40,250 (Direct) | View |
2024-10-15 Option Award | 2024-10-17 5:04 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 15,000 | $0 | 171,009 (Direct) | View |
2024-07-11 Option Award | 2024-07-12 4:33 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 15,000 | $0 | 48,107 (Direct) | View |
2024-07-11 Option Award | 2024-07-12 4:33 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | 15,000 | $0 | 186,382 (Direct) | View |
2024-07-08 Tax Withholding | 2024-07-10 4:02 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 85 | $8.13 | 24,333 (Direct) | View |
2024-06-08 Tax Withholding | 2024-06-11 4:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | 2,376 | $6.19 | 171,382 (Direct) | View |
2024-06-08 Tax Withholding | 2024-06-11 4:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business | 464 | $6.19 | 24,418 (Direct) | View |
2024-06-08 Tax Withholding | 2024-06-11 4:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 1,249 | $6.19 | 163,134 (Direct) | View |
2024-06-08 Tax Withholding | 2024-06-11 4:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer | 2,733 | $6.19 | 156,009 (Direct) | View |
2024-06-08 Tax Withholding | 2024-06-11 4:10 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices | 1,167 | $6.19 | 33,107 (Direct) | View |
2024-05-23 Option Award | 2024-05-28 9:41 pm | N/A 2031-05-22 | Emergent BioSolutions Inc. | EBS | Katkin Keith Director | 43,178 | $0 | 85,620 (Direct) | View |
2024-05-23 Option Award | 2024-05-28 9:41 pm | N/A 2031-05-22 | Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director | 43,178 | $0 | 161,848 (Direct) | View |
2024-05-23 Option Award | 2024-05-28 9:41 pm | N/A 2031-05-22 | Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director | 43,178 | $0 | 161,848 (Direct) | View |
2024-05-23 Option Award | 2024-05-28 9:40 pm | N/A 2031-05-22 | Emergent BioSolutions Inc. | EBS | White Marvin L Director | 43,178 | $0 | 94,127 (Direct) | View |